Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/29/2026 | Q4 | $6.9B | -- | -- | -- | -- |
| 11/14/2025 | Q3 | $7.5B | $17B | $0.98 | -- | -- |
| 07/31/2025 | Q2 | $7.5B | $15.9B | $0.67 | -- | -- |
| 05/14/2025 | Q1 | $6.4B | $15.4B | $0.07 | -- | -- |
| 01/28/2025 | Q4 | $3.3B | $15.5B | $0.69 | -- | -- |
| 11/14/2024 | Q3 | $6.5B | $16.4B | $0.61 | -- | -- |
| 08/02/2024 | Q2 | $6.5B | $15.2B | $0.61 | -- | -- |
| 05/15/2024 | Q1 | $5.5B | $17B | $0.29 | -- | -- |
| 02/01/2024 | Q4 | $5.6B | $15.6B | $0.45 | -- | -- |
| 11/14/2023 | Q3 | -- | $14.9B | $0.48 | -- | -- |
| 07/28/2023 | Q2 | -- | $14.9B | $0.45 | -- | -- |
| 05/15/2023 | Q1 | -- | $13.7B | $0.07 | -- | -- |
| 01/30/2023 | Q4 | -- | $11.5B | $0.42 | -- | -- |
| 11/14/2022 | Q3 | -- | $11B | $0.48 | -- | -- |
| 07/28/2022 | Q2 | -- | $9.1B | $0.47 | -- | -- |
| 05/13/2022 | Q1 | -- | $9.8B | $0.17 | -- | -- |
| 02/02/2022 | Q4 | -- | $8.9B | $0.36 | -- | -- |
| 11/12/2021 | Q3 | -- | $9B | $0.56 | -- | -- |
| 07/30/2021 | Q2 | -- | $8.4B | $0.45 | -- | -- |
| 05/14/2021 | Q1 | -- | $9.3B | $0.18 | -- | -- |
| 02/02/2021 | Q4 | -- | $8.9B | $0.38 | -- | -- |
| 09/30/2020 | Q3 | -- | $9.1B | $0.42 | -- | -- |
| 06/30/2020 | Q2 | -- | $8.9B | $0.19 | -- | -- |
| 05/15/2020 | Q1 | -- | $9.9B | $0.21 | -- | -- |
| 01/30/2020 | Q4 | -- | $10.2B | $0.40 | -- | -- |
| 09/30/2019 | Q3 | -- | $10.9B | $0.49 | -- | -- |
| 06/30/2019 | Q2 | -- | $10.3B | $0.47 | -- | -- |
| 05/16/2019 | Q1 | -- | $12B | $0.19 | -- | -- |
| 01/31/2019 | Q4 | -- | $12.8B | $0.35 | -- | -- |
| 09/30/2018 | Q3 | -- | $13.3B | $0.53 | -- | -- |
| 06/30/2018 | Q2 | -- | $12.7B | $0.49 | -- | -- |
| 05/14/2018 | Q1 | -- | $13.7B | $0.19 | -- | -- |
| 01/31/2018 | Q4 | -- | $13.2B | $0.48 | -- | -- |
| 09/30/2017 | Q3 | -- | $12.3B | $0.38 | -- | -- |
| 07/31/2017 | Q2 | -- | $12B | $0.51 | -- | -- |
| 05/15/2017 | Q1 | -- | $11.7B | $0.34 | -- | -- |
| 01/27/2017 | Q4 | -- | $12.2B | $0.41 | -- | -- |
| 09/30/2016 | Q3 | -- | $11.3B | $0.42 | -- | -- |
| 06/30/2016 | Q2 | -- | $10.8B | $0.42 | -- | -- |
| 05/13/2016 | Q1 | -- | $10B | $0.04 | -- | -- |
| 01/26/2016 | Q4 | -- | $9.7B | $0.48 | -- | -- |
Sumitomo Mitsui Financial Group, Inc. reported $17B worth of top line sales in its most recent quarter.
Sumitomo Mitsui Financial Group, Inc. announced earnings per share of $0.98 which represents a beat of analyst forecast a -- per share.
Sumitomo Mitsui Financial Group, Inc. reported -- that represents -- per share over the last quarter.
Sumitomo Mitsui Financial Group, Inc.'s earnings are forecast to grow from $1.98 per share to -- per share next year representing an increase of --.
Sumitomo Mitsui Financial Group, Inc.'s next earnings date is January 29, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.